Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

about

Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.

P2860

Q50045474-085464DF-7F94-412A-A59E-0D4198012D7A

P2860

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

Item

http://www.wikidata.org/entity/Q50045424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@en

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@nl

type

Item

label

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@en

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@nl

prefLabel

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@en

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@nl

P1476

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

@en

P2093

Gregory J Tsongalis

http://www.w3.org/2001/XMLSchema#string

William B Coleman

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Crizotinib resistance: implications for therapeutic strategies

The influence of subclonal resistance mutations on targeted cancer therapy

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Toward understanding and exploiting tumor heterogeneity

Epidermal growth factor receptor mutations in lung cancer

P304

S60-S66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.934

http://www.w3.org/2001/XMLSchema#string

P478

57 Suppl 10

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28921651

http://www.w3.org/2001/XMLSchema#string

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

about

P2860

P2860

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698